MC2 has all patients in place for phase II trial of skin disease drug
Privately held Danish biotech company Union Therapeutics is one step closer to the market for the treatment of patients with urea-related skin diseases.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.